🌀 Attention! Deal °85-IPO of Taisha Gene Therapy (THE) biotechs

Stock market. Stocks. IPO Taysha Gene Therapies — TSHA) - September 24, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 14-00 Moscow time on 23.09.2020), which specializes in the development of methods for treating the Central nervous system through gene therapy. The placement is underwritten by Goldman Sachs, Morgan Stanley and Jefferies. Boutique rating:3 scoop Rating: 2 Oversubscription: 200% Allocation: up to 50%

2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF in the Fund (additional data on request in PM)